Ranking Year:
# | Company Name | Region | Tech Topics | Total |
|---|
1 |  STARTUP | Patent: 13 | ||
2 | Patent: 11 | |||
3 | Patent: 3 | |||
4 | Patent: 3 | |||
5 | Patent: 2 |
Top 5 Key Players companies in Insulin pen
by Most Patent Filings in the United States in 2021
The Insulin pen top 5 is Discovery PatSnap’ annual ranking of the top 5 Most Patent Filings Insulin pen Key Players in the United States. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2021, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
An insulin pen is used to inject insulin for the treatment of diabetes. Insulin is a hormone produced by the pancreas. It is composed of an insulin cartridge (integrated or bought separately) and a dial to measure the dose, and is used with disposable pen needles to deliver the dose. It was introduced and marketed as NovoPen by the Danish company Novo Nordisk in 1985.
Page generation time:
Apr 26 2025